These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparison of the long-term effects of various topical antiglaucoma medications on meibomian glands. Arita R, Itoh K, Maeda S, Maeda K, Furuta A, Tomidokoro A, Aihara M, Amano S. Cornea; 2012 Nov; 31(11):1229-34. PubMed ID: 22406943 [Abstract] [Full Text] [Related]
3. Eyelid and eyelash changes due to prostaglandin analog therapy in unilateral treatment cases. Yoshino T, Fukuchi T, Togano T, Seki M, Ikegaki H, Abe H. Jpn J Ophthalmol; 2013 Mar; 57(2):172-8. PubMed ID: 23208023 [Abstract] [Full Text] [Related]
4. The Association of Chronic Topical Prostaglandin Analog Use With Meibomian Gland Dysfunction. Mocan MC, Uzunosmanoglu E, Kocabeyoglu S, Karakaya J, Irkec M. J Glaucoma; 2016 Sep; 25(9):770-4. PubMed ID: 27513901 [Abstract] [Full Text] [Related]
5. Effects of long-term topical anti-glaucoma medications on meibomian glands. Arita R, Itoh K, Maeda S, Maeda K, Furuta A, Tomidokoro A, Aihara M, Amano S. Graefes Arch Clin Exp Ophthalmol; 2012 Aug; 250(8):1181-5. PubMed ID: 22349978 [Abstract] [Full Text] [Related]
7. Prostaglandin-Associated Periorbitopathy in Children and Young Adults with Glaucoma. Kim JS, Blizzard S, Woodward JA, Leyngold IM, Liss J, Freedman SF. Ophthalmol Glaucoma; 2020 Aug; 3(4):288-294. PubMed ID: 33008561 [Abstract] [Full Text] [Related]
12. Periorbital changes associated with prostaglandin analogs in Korean patients. Kim HW, Choi YJ, Lee KW, Lee MJ. BMC Ophthalmol; 2017 Jul 17; 17(1):126. PubMed ID: 28716077 [Abstract] [Full Text] [Related]
13. Hypertrichosis and increased pigmentation of eyelashes and adjacent hair in the region of the ipsilateral eyelids of patients treated with unilateral topical latanoprost. Johnstone MA. Am J Ophthalmol; 1997 Oct 17; 124(4):544-7. PubMed ID: 9323945 [Abstract] [Full Text] [Related]
14. Clicking Eyelids: A New Finding of Prostaglandin-Associated Periorbitopathy. Skorin L, Dailey KH. Optom Vis Sci; 2016 Jul 17; 93(7):779-81. PubMed ID: 27055061 [Abstract] [Full Text] [Related]
15. Latanoprost-induced prostaglandin-associated periorbitopathy. Tan J, Berke S. Optom Vis Sci; 2013 Sep 17; 90(9):e245-7; discussion 1029. PubMed ID: 23912967 [Abstract] [Full Text] [Related]
16. [Side-effects and risk profile of latanoprost 0.005% (Xalatan)]. Schlote T. Ophthalmologe; 2002 Sep 17; 99(9):724-9. PubMed ID: 12219263 [Abstract] [Full Text] [Related]
17. Prostaglandin analogues: A double-edged sword in orbital glaucoma disease management. Joganathan V, Cannon PS, Mercieca K. Eur J Ophthalmol; 2021 May 17; 31(3):NP40-NP44. PubMed ID: 32043370 [Abstract] [Full Text] [Related]
18. Eyelid Changes Related to Meibomian Gland Dysfunction in Early Middle-Aged Patients Using Topical Glaucoma Medications. Kim JH, Shin YU, Seong M, Cho HY, Kang MH. Cornea; 2018 Apr 17; 37(4):421-425. PubMed ID: 29227342 [Abstract] [Full Text] [Related]